MicroRNAs of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the IRAK1/TAB2/NF-κB pathway-Reference-Cited by-同舟云学术

MicroRNAs of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the IRAK1/TAB2/NF-κB pathway

Published:2023-04 Issue: Volume:28 Page:131-140
ISSN:1542-0124
Container-title:The Ocular Surface
language:en
Short-container-title:The Ocular Surface

Author:

Wang Leying^ORCID,Wang Xueyao,Chen Qiankun,Wei Zhenyu,Xu Xizhan,Han Deqiang,Zhang Yuheng,Chen Zhiguo,Liang Qingfeng^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Ophthalmology

Reference55 articles.

1. TFOS DEWS II pathophysiology report;Bron;Ocul Surf,2017

2. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older;Farrand;Am J Ophthalmol,2017

3. TFOS DEWS II epidemiology report;Stapleton;Ocul Surf,2017

4. Relationship between screen time and dry eye symptoms in pediatric population during the COVID-19 pandemic;Elhusseiny;Ocul Surf,2021

5. Patients' perceived treatment effectiveness in dry eye disease;Kheirkhah;Cornea,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An injectable decellularized extracellular matrix hydrogel with cortical neuron-derived exosomes enhances tissue repair following traumatic spinal cord injury;Materials Today Bio;2024-09

2. Multifunctional cerium oxide nanozymes with high ocular surface retention for dry eye disease treatment achieved by restoring redox balance;Acta Biomaterialia;2024-09

3. Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases;ACS Nano;2024-08-14

4. Th1/Th2 cytokines in early peripheral blood of patients with multiple injuries and its predictive value for SIRS: A bioinformatic analysis;SLAS Technology;2024-08

5. Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders;Survey of Ophthalmology;2024-08